This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Complications

Authoring team

The main complications of peptic ulceration are:

  • gastrointestinal bleeding - occurs in 25% to 33% of cases and accounts for 25% of ulcer deaths. Haemorrhage arises from the small blood vessels at the base of the ulcer. Uncommonly, it may be the initial presentation of a peptic ulcer. (1) In patients whose ulcers have bled, eradication of H. pylori is more effective than long-term acid suppression without eradication. (2)
  • perforation and penetration into adjacent structures - pancreas, liver and retroperitoneal space. (3)
  • gastric outflow obstruction / pyloric stenosis:
    • reversible - from oedema and spasm
    • irreversible - from cicatricial stenosis

Malignant transformation has been reported in gastric ulcers but it is more likely that such "ulcers" were malignant in their inception.

 

Reference:

  1. National Institute for Health and Care Excellence. Acute upper gastrointestinal bleeding in over 16s: management. August 2016 [internet publication].
  2. Gisbert JP et al. H. pylori eradication therapy vs. anti-secretory non-eradication therapy (with or without long-term maintenance anti-secretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev. 2004;(2):CD004062.
  3. Narayanan M, Reddy KM, Marsicano E. Peptic Ulcer Disease and Helicobacter pylori infection. Mo Med. 2018 May-Jun;115(3):219-224.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.